Latest Breaking News On - Cormorant asset management - Page 6 : comparemela.com

Oppenheimer Increases Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target to $60 00

Oppenheimer Increases Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target to $60 00
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Mirae asset global investments coCorbus pharmaceuticals price performanceNews ratings for corbus pharmaceuticals dailyJefferies financial groupCorbus pharmaceuticalsCorbus pharmaceuticals holdings incVanguard group incFree reportFinancial groupGet free reportCormorant asset managementAsset global investmentsPharmaceuticals holdingsCorbus pharmaceuticals daily

StockNews com Downgrades EyePoint Pharmaceuticals (NASDAQ:EYPT) to Sell

StockNews com Downgrades EyePoint Pharmaceuticals (NASDAQ:EYPT) to Sell
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Vanguard group incHermes incEyepoint pharmaceuticalsEyepoint pharmaceuticals incJennison associatesInstitutional investors weigh in on eyepoint pharmaceuticalsSecurities exchange commissionJpmorgan chase coEyepoint pharmaceuticals company profileEyepoint pharmaceuticals stock downNews ratings for eyepoint pharmaceuticals dailyAnalyst recommendations for eyepoint pharmaceuticalsFranklin resources incFree reportOne financialModerate buy

Aardvark Therapeutics secures $85m in Series C funding round

Aardvark Therapeutics secures $85m in Series C funding round
pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.

United statesTien leeLg technology venturesPrader willi syndrome associationFoundation for prader willi researchTetragon financial groupCormorant asset managementSurveyor capitalWalleye capitalLaurion capital managementCantor venturesSilver arc private capitalVickers venture partnersPrader willi researchDecheng capitalVictor tong

EyePoint Pharmaceuticals (NASDAQ:EYPT) Downgraded by StockNews com

EyePoint Pharmaceuticals (NASDAQ:EYPT) Downgraded by StockNews com
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdJennison associatesInstitutional trading of eyepoint pharmaceuticalsFranklin resources incFirst turn managementEyepoint pharmaceuticals company profileEyepoint pharmaceuticals incSecurities exchange commissionHermes incEyepoint pharmaceuticalsAnalyst recommendations for eyepoint pharmaceuticalsEyepoint pharmaceuticals stockJpmorgan chase coNews ratings for eyepoint pharmaceuticals dailyGet free reportOne financial

Chardan Capital Comments on EyePoint Pharmaceuticals, Inc s FY2025 Earnings (NASDAQ:EYPT)

Chardan Capital Comments on EyePoint Pharmaceuticals, Inc s FY2025 Earnings (NASDAQ:EYPT)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesEyepoint pharmaceuticals incInsider transactions at eyepoint pharmaceuticalsInstitutional investors weigh in on eyepoint pharmaceuticalsProshare advisorsLegacy capital group california incNews ratings for eyepoint pharmaceuticals dailyEyepoint pharmaceuticals stock performanceSwiss national bankEssex investment management coJpmorgan chase coEyepoint pharmaceuticalsFree reportChardan capitalEyepoint pharmaceuticalOne financial